Webinar: Commercialisation & regulatory strategies for women’s health technology
Date: July 24 2024
Time: 2:00PM BST
Presented by: Robin Stephens, CEO & Co-Founder, Psephos Biomedica and Erica Kantor, Head of Women’s Health, Sagentia Innovation
Hosted by: Science and Engineering Health Technologies Alliance (SEHTA)
Register here for the webinar
Psephos and Sagentia Innovation will be discussing the challenges women’s health start-ups face when developing their commercialisation strategies, particularly when choosing a regulatory pathway.
Is it better to take a direct-to-consumer approach? Or should you pursue a regulated medical device pathway?
Join our webinar to learn how – and when – to define your regulatory strategy to ensure your next women’s health innovation is a success.
Robin Stephens and Erica Kantor will be discussing:
- The emerging women’s health technology landscape
- The challenges women’s health start-ups face when developing and commercialising new solutions
- The pros and cons of the direct-to-consumer approach, vs seeking regulatory approval
- The key considerations in developing a successful commercialisation strategy